Aagaard 2009 showed partial rescue of nitrogen wasting, though less effectively than exogenous GH
But TB-500 as sold in grey markets is not the same thing as a well-characterized pharmaceutical product, and the FDAs Category 2 listing includes Thymosin Beta-4, Fragment (LKKTETQ) as a substance raising significant safety risks in compounding contexts
These preclinical results prompted off-label use in humans, primarily through compounding pharmacies and peptide clinics
The main features of chronic wounds include a prolonged inflammatory phase, excessive infiltration of neutrophils, persistent infection and high levels of MMPs
Some adverse effects may originate from the off-target proteins
In pharmacological research, findings from a single lab regardless of how extensive carry substantially less weight than findings replicated across multiple independent groups